The comparison between field trials and mouse protection tests against intranasal and intracerebral challenges with Bordetella pertussis.

PubWeight™: 2.34‹?› | Rank: Top 2%

🔗 View Article (PMC 1423901)

Published in Immunology on April 01, 1958

Authors

A F STANDFAST

Articles citing this

A report on the laboratory assays carried out at the Lister Institute of Preventive Medicine on the typhoid vaccines used in the field study in Yugoslavia. Bull World Health Organ (1960) 2.18

The pathogenic properties of Fusobacterium and Bacteroides species from wallabies and other sources. J Hyg (Lond) (1984) 1.89

The intracerebral infection of mice with Bordetella pertussis. J Hyg (Lond) (1961) 1.46

The intranasal infection of mice with Bordetella pertussis. J Hyg (Lond) (1961) 1.33

Characterization of the antibodies responsible for the 'bactericidal activity patterns' of antisera to Bordetella pertussis. Immunology (1965) 1.24

Proliferative response of immune mouse T-lymphocytes to the lymphocytosis-promoting factor of Bordetella pertussis. Infect Immun (1984) 0.95

The effects of humoral, cellular and non-specific immunity on intracerebral Bordetella pertussis infections in mice. J Hyg (Lond) (1975) 0.94

Why the MRC randomized trials of whooping cough (pertussis) vaccines remain important more than half a century after they were done. J R Soc Med (2007) 0.90

Antigens of Bordetella pertussis V. Separation of Agglutinogen 1 and Mouse-Protective Antigen. Infect Immun (1971) 0.87

Quantitative priming with inactivated pertussis toxoid vaccine in the aerosol challenge model. Infect Immun (2002) 0.84

Protective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge model. Clin Diagn Lab Immunol (1999) 0.83

A comparison between the intranasal and intracerebral infection of mice with Bordetella pertussis. J Hyg (Lond) (1961) 0.75